Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

22nd Century Group Inc (NQ: XXII )

1.690 +0.020 (+1.19%)
Streaming Delayed Price Updated: 10:16 AM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about 22nd Century Group Inc

< Previous 1 2 3 Next >
22nd Century Group (Nasdaq: XXII) Reports First Quarter 2023 Financial Results, Introduces 2023 Full Year Revenue Outlook
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (XXII) Announces Strategic License, Manufacturing and Distribution Agreement with Old Pal
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives
Supports Accelerated Expansion of VLN Multi-State Retail Channels, GVB Global Ingredients and CDMO Business 
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealand’s Reduced-Nicotine Content Tobacco Law
From 22nd Century Group, Inc
Via GlobeNewswire
Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That “Helps You Smoke Less”
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
Partnership Will Provide Pharmaceutical Grade Cannabinoid Active Ingredients to the Largest Pharmaceutical and Consumer Goods Names in the Industry 
From 22nd Century Group, Inc
Via GlobeNewswire
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews John Miller President, 22nd Century Group Inc.
Via ACCESSWIRE
22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands
New distribution facility supports rapidly growing demand for hemp/cannabis products 
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022
From 22nd Century Group, Inc
Via GlobeNewswire
New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) to Participate in the Dawson James Small Cap Growth Conference on October 12
From 22nd Century Group, Inc
Via GlobeNewswire
First Cigarette Authorized by FDA to “Help You Smoke Less” Now Available Across Colorado
From 22nd Century Group, Inc
Via GlobeNewswire
22nd Century Group (Nasdaq: XXII) Expands VLN® Distributor Network with the Addition of Specialty Distributor Creager Mercantile
From 22nd Century Group, Inc
Via GlobeNewswire
Global Next-Generation Tobacco Product Market Expected To Reach $67 Billion In 2030
Palm Beach, FL – September 22, 2022 – FinancialNewsMedia.com News Commentary – The Alternative Tobacco products market has been growing in recent years and is projected to continue to grow in the years... 
Via FinancialNewsMedia
Americans Now Smoking More Marijuana Than Cigarettes
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a recent Gallup poll, regular cannabis use in the US has surpassed regular cigarette... 
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2022 Results on August 9, 2022
From 22nd Century Group, Inc
Via GlobeNewswire
InvestorNewsBreaks – 22nd Century Group Inc. (NASDAQ: XXII) Piloting Sales of First 95% Reduced Nicotine Content Cigarette
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
TinyGemsBreaks – SRAX Inc. (NASDAQ: SRAX) Shares Replays of 2022 LD Micro Invitational Company Presentations
Via Investor Brand Network
InvestorNewsBreaks – 22nd Century Group Inc. (NASDAQ: XXII) Welcomes John J. Miller to Its Tobacco Business
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.